In B cell malignancies, several methods have been minimal residual disease (MRD) in B cell tumors. Chromosomal developed for the detection of MRD.
ing (J) segments, to generate antigen-specific receptors. The rearranged variable region (VDJ) is composed of four relatively conserved regions, called framework (FR), interrupted by three Introduction complementarity-determining regions (CDR). CDRs codify for the antigen-binding site and are unique for each B cell B cell malignancies are a heterogeneous group of disorders clone. 17 In B cell malignancies, CDRs are utilized to design characterized by the proliferation of clonal cells at various patient-specific primers and probes for the amplification and stages of differentiation. In recent years, intensified chemohybridization procedures for MRD detection. 11, 18 Although radiotherapy programs followed by autologous or allogeneic such procedures are sensitive and specific, the hybridization bone marrow transplantation have been successfully step is expensive, time-consuming and requires the use of a employed for the treatment of these tumors. Although comradioactive labeled probe. Nested-PCR has been recently used plete remissions (CR) are often achieved, disease relapse for MRD detection in order to bypass the hybridization step. remains the leading cause of death in these patients.
1-3
Nested-PCR is a simple nonradioactive procedure which is The analysis of minimal residual disease (MRD) has currently used when tumor-specific translocations are present, assumed a growing role in the evaluation of tumor cell conproviding the same sensitivity and specificity of amplification tamination of autografts and during molecular follow-up of hybridization procedures. 19 patients otherwise in CR. [4] [5] [6] It has recently been shown that In the present study, we show a nested-PCR approach for patients with chronic myelogenous leukemia, acute the detection of MRD using IgH genes. Double amplification promyelocytic leukemia, acute lymphoblastic leukemia or folusing specific primers derived from tumor CDRs (CDRII and licular non-Hodgkin's lymphoma may remain PCR-positive CDRIII) has been employed. Our approach has been tested after chemotherapy or transplantation procedures. The persiston a panel of 75 B cell tumors including seven ALL, 22 NHL, ence of such a positivity has been correlated with a higher nine chronic lymphocytic leukemia (CLL) and 37 multiple frequency of relapse. VH1  5′-CCATGGACTGGACCTGGAGG-3′  VH1  5′-CTCACCATGGACTGGACCTGGAG-3′  VH2  5′-ATGGACATACTTTGTTCCAG-3′  VH2  5′-ATGGACATACTTTGTTCCACGCTC-3′  VH3  5′-CCATGGAGTTTGGGCTGAGC-3′  VH3  5′-CCATGGAGTTTGGGCTGAGCTGG-3′  VH4  5′-ATGAAACACCTGTGGTTCTT-3′  VH4  5′-ACATGAAACA(C/T)CTGTGGTTCTTCC-3′  VH5  5′-ATGGGGTCAACCGCCATCCT-3′  VH5  5′-ATGGGGTCAACCGCCATCCTCCG-3′  VH6  5′-ATGTCTGTCTCCTTCCTCAT-3′  VH6  5′-ATGTCTGTCTCCTTCCTCATCTTC- Patients and nucleic acid extraction and extension 72°C for 30 s) with a final extension of 7 min. The prevention of PCR contamination was performed as preSeventy-five patients with B cell tumors were selected for this study. PB, BM and lymph node samples were obtained during viously described. 25 PCR products were analyzed by electrophoresis on 2% agarose gel. Direct sequencing of amplified standard diagnostic procedures. They had different degrees of tumor infiltration, ranging from 2 to 90%. BM and/or PB cells DNAs was performed using the Promega fmol sequencing system as previously described. 26 Reactions were carried out in were separated on a Ficoll-Hypaque density gradient. DNA was obtained by cell lysis, phenol extraction and ethanol prea thermocycler at 68°C annealing temperature for 15 cycles.
When the sequence quality did not allow a complete reading cipitation. 20 RNA was isolated using RNAzol B method (Biotex Laboratories, Houston, TX, USA). Total cDNA synof CDR regions, DNA was reamplified with primers containing EcoRI and HindIII restriction sites, and cloned in a thesis was carried out as follows: total RNA (5 g) was reverse-transcribed with 20 pmol of reverse transcription Bluescript SK vector (Stratagene, San Diego, CA, USA). 20 Restriction enzyme analysis was carried out on plasmid DNAs primer (C1: 5′-AAGGAAGTCCTGTGCGAGG-3′, C␥1: 5′-GGAAGTAGTCCTTGACCAG-3′, C␣1: 5′-AGAAGCCCTprepared by the alkaline lysis method, and miniprep plasmid DNAs were then sequenced. The analysis of sequencing was GGACCAGGCA-3′). A 50-l reaction was performed in 10 mmol/l dithiothreitol, 1 mmol/l deoxynucleoside triphosperformed using the PC-GENE software (IntelliGenetics, Mountain View, CA, USA). Nested-PCR for IgH rearrangement was carried out as follows: for DNA samples, 1 g of genomic DNA was amplified using USA). The reaction mixture was incubated for 1 h at 37°C. After cDNA synthesis, reverse transcriptase was heat-inactia consensus primer derived from the tumor VH family and an antisense derived from the 3′ end of the JH region (JH3). The vated for 5 min at 95°C. first reaction was carried out for 28 cycles (denaturation 94°C for 30 s, annealing 64°C for 30 s, extension 72°C for 30 s) with a final extension of 7 min. One l of amplified DNA was then Amplification and sequencing of the tumor VDJ reamplified using CDRII sense and CDRIII antisense primers using 2.5 U of AmpliTaq Gold (PE Applied Biosystems, Roche VDJs were amplified starting from genomic DNA or total cDNA depending on sample availability. Amplifications were Molecular Systems, Branchburg, NJ, USA). The second reaction was carried out for 35 cycles (denaturation 94°C for 30 s, performed as previously described. 18 Briefly, 1 g of genomic DNA or 1 l of total cDNA, was amplified using two sets of annealing depending on specific primers melting temperature (T m ) for 30 s, extension 72°C for 30 s) with a final extension consensus sense primers derived from the IgH leader region and FR1 respectively [21] [22] [23] [24] (Tables 1 and 2) , and an antisense of 7 min. For cDNA samples, 1 l of cDNA (prepared from Table 2 Amplification of the tumor VDJ primers derived from the first framework region
5 g of total RNA as described above) was amplified using formed as described in the Materials and methods section, showed that the most common VH family used was VH3 CDRII primer with an antisense primer derived from the first exon of the IgH tumor constant region (CH1, the same primer (61%) for all B cell malignancies studied, in particular 57% of ALL, 50% of NHL, 49% of MM and 55% of CLL. The most used in RT reaction). Amplification was carried out for 28 cycles (denaturation 94°C for 30 s, annealing depending on represented JH was JH4, especially in MM (49%) and NHL (36%), followed by JH6 (29% in ALL, 19% in MM, 33% in specific primer T m , extension 72°C for 30 s). Second PCR reaction was performed using a primer derived from CDRIII and CLL and 9% in NHL). Tumor-specific primers for nested-PCR to detect MRD were derived from CDRs sequences. For each an internal antisense primer derived from the IgH constant region (CH2) (C2: 5′-CAGGAGACGAGGGGGAAA-3′, C␥2:
patient CDRII sequence was used to synthesize a sense primer, while the CDRIII sequence was used to synthesize 5′-CAGAGGTGCTCCTGGAGCA-3′, C␣2: 5′-ACCACG-TTCCCATCTGGCTG-3′). The first and the second reactions either a sense or an antisense primer as described in the Materials and methods section. were performed using AmpliTaq Gold (PE Applied Biosystems) Specific primers for the second reaction were selected, when possible, with a slightly higher melting temperature to minimize inappropriate annealing of primers used during the first Double strategy to detect MRD with IgH nested-PCR amplification. PCR products were visualized on a 3% Metaphor agarose gel (FMC Bioproducts, Rockland, ME, USA)
Nested-PCR using CDRII and CDRIII primers was successfully performed in all patients in which VDJ sequence was availstained with ethidium bromide (0.5 g/ml). Two polyclonal DNAs were always used as negative controls.
able. For each patient, the specificity of the method was evaluated by amplifying two polyclonal DNAs under the same Sensitivity experiments were performed diluting both cell lines and tumor cells from patients (with at least 90% of circulconditions of tumor DNA and no amplifications were observed. In order to determine whether the amplification for ating tumor cells) with normal marrow cells (up to one tumor cell in 10 6 normal marrow cells). Cell mixtures were pelleted MRD detection is more efficient when performed on RNA with an RT-nested PCR based approach or on genomic DNA and resuspended in 10 l of H 2 O and then lysed by heating at 95°C for 5 min with 10 U of ribonuclease inhibitor (RNasin;
with a simple nested-PCR, two experimental strategies were adopted and compared. Both methods were used depending Promega). The whole lysate from each serial dilution was amplified with specific nested primers for DNA strategy, on sample availability. On DNA samples the strategy, called DNA strategy, was based on a first amplification with a sense otherwise reverse transcribed into cDNA in a total volume of 20 l. The whole cDNA was then amplified following the preprimer derived from patient clonal VH family and an antisense primer derived from the 3′ end of the JH region. Samples were viously described conditions in a 100 l final volume.
then reamplified with patient-specific CDR primers: CDRII sense and CDRIII antisense primers (Figure 2 ). On RNA samples the approach, called cDNA strategy, involved a
Oligonucleotide synthesis reverse transcription reaction to obtain tumor-specific IgH cDNA followed by a two-round amplification. Both amplifiOligonucleotides were chemically synthesized with a 391 PCR-MATE EP, DNA synthesizer (Applied Biosystems, Foster cations were performed with 5′ sense primers derived from patient-tumor CDRs (CDRII and CDRIII) and 3′ antisense priCity, CA, USA) on a 0.2 mol scale, according to the users' manual.
mers derived from the first exon of the tumor IgH constant region (Figure 3 ). All the patients examined gave a band of the expected size. No false positive results were observed in any strategy. Overall, we could perform both strategies on 40 Results patients (31 MM, seven NHL, two CLL). DNA strategy was used for all the ALL patients as most of them do not express Identification of VDJ sequence the chain in the cytoplasm. DNA strategy was also used when only DNA samples were available (two MM, 10 NHL, VDJ regions were amplified using two sets of 5′ consensus primers derived from the leader or FR1 region of IgH genes four CLL). In order to compare the sensitivity of both strategies, two amplifications were performed on serial dilutions on and a 3′ primer from the JH region. First, specimens were amplified with 5′ consensus primer from FR1 and tumor VDJ either DNA or RNA of a Burkitt lymphoma cell line (BJAB). The sensitivity was higher with the cDNA strategy as it was obtained by direct sequencing in 31 patients; then remaining amplified VDJs were cloned in a plasmid vector.
allowed the detection of one tumor cell in 10 6 normal marrow cells, while the DNA strategy reached the sensitivity of one For each patient 10 to 15 clones were sequenced and a predominant clone was found in 15 patients. Alternatively, those tumor cell in 10 5 normal marrow cells. Sensitivity experiments were also performed on 10 patients, diluting tumor cells with patients whose VDJ sequence was impossible to obtain with FR1 amplification, were amplified with 5′ consensus primer normal marrow cells. The results were similar to those obtained with the cell line: a 10 times lower sensitivity was from the leader region and then sequenced directly or cloned. Tumor VDJ was obtained by direct sequence only in five usually obtained with DNA strategy. We also compared these data with the results previously obtained in 55 patients using patients, while cloning and sequencing was successful in 11 patients. Overall, complete sequence of the tumor VDJ was the hybridization procedure: the tumor clone was amplified with CDRII and JH or CH primers and then hybridized to a obtained in 62 patients out of 75 (83%) (77% of NHL, 86% of ALL, 66% of CLL and 89% of MM patients) (Figure 1 ). Prob-CDRIII probe. IgH nested-PCR results were identical showing the same sensitivity and specificity of the hybridization ably, either the presence of somatic mutations or the use of unknown variable regions were the cause of the lack of ampliprocedure. An alternative approach suitable for DNA and RNA temfication in 13 patients. There was no correlation between a successful amplification of VDJ region and the number of plates was also performed, based on a nested-PCR with sense primers derived from the tumor CDRs (CDRII and CDRIII) and tumor cells in the diagnostic sample. Sequence analysis, per- cDNA strategy. RT-nested PCR for immunoglobulin the detection of residual tumor cells. Genomic DNA was first ampligenes using RNA-cDNA samples. (a) Schematic representation of fied using 5′ tumor VH family primer and 3′ JH primer (VH, JH3), and nested-PCR for the detection of residual tumor cells. Total cDNA was then an aliquot of the first reaction was reamplified using inner prifirst amplified using outer primers (CDRII, CH1) and then an aliquot mers derived from tumor CDRII and CDRIII. Amplified DNA was then of the first reaction was reamplified using inner primers (CDRIII, CH2). run on 3% Metaphor gel. (b) PCR dilution experiment demonstrating Amplified DNA was then run on 3% Metaphor gel. (b) PCR dilution assay sensitivity and specificity in the BJAB cell line. MW, molecular experiment demonstrating assay sensitivity and specificity in the BJAB weight marker; P, BJAB DNA; PL, unrelated polyclonal DNA; N, no cell line. MW, molecular weight marker; P, BJAB DNA; PL, unrelated DNA control lane. polyclonal cDNA; N, no DNA control lane.
two different antisense primers from the JH 3′ end. This strattumor IgH constant region antisense primers are used, increasing on one hand the sensitivity and on the other decreasing egy failed to yield satisfactory results: nested-PCR products were usually very short (50-60 bp) due to deletion of the 5′ the risk of false positive results. This procedure always gave cleaner products reducing the possibility of nonspecific end of the JH region and due to few N insertions between D segments and JH regions during IgH genes rearrangement.
annealing. Moreover, the use of a IgH constant region primer avoids the use of JH antisense primer that sometimes fails to Resulting bands were often so faint they were hardly visualized on 3% Metaphor gel (data not shown).
give amplification because of extensive deletion in its sequence, especially in MM and ALL. 29, 30 DNA is a good source for MRD detection when only smears or old (badly preserved) material are available and RNA Discussion extraction could fail. In this case it is advisable to proceed with RNA and DNA extraction simultaneously. If RNA extracIn the present study, we describe a novel nested PCR-method for MRD detection in B cell malignancies using the rearrangetion fails, the DNA strategy provides a possible alternative. It consists of an initial amplification with the 5′ tumor VH family ment of IgH genes. This method employs tumor-specific primers derived from the tumor CDRs.
primer and the 3′ JH primer, followed by a second amplification using CDRII and CDRIII. The use of a VH consensus Several methods have been developed to evaluate MRD using the IgH rearrangement. Most of these methods are based primer in the first PCR may lead to amplification of normal clones unrelated to the tumor one, thus decreasing the sension the amplification of a small portion of the tumor VDJ by using consensus primers derived from the FR3. Amplification tivity of the second specific amplification. Although the use of the IgH genes as tumor markers still with a FR3 primer is often unsuccessful because of the presence of many somatic mutations in the primer template that remains a relatively complex procedure, especially because of VDJ sequencing, the use of nested-PCR may greatly simplify prevent correct annealing rendering this approach of limited application, especially in those B cell malignancies in which B the screening for residual tumor cells in remission samples. This is particularly useful when frequent molecular monitoring lymphocytes have already been exposed to the hypermutation mechanism (MM and NHL). In addition, most of the ALL in is required. which amplification with FR3 primer fail, have a loss of 3′ portion of the primer site, presumably as a consequence of exonuclease activity at the time of recombination. 27 MoreAcknowledgements over, such a method allows the reading of the CDRIII only, that is usually 20 nucleotides long (sometimes less than 15) This work has been supported by Associazione Italiana and that can just be employed to derive a tumor-specific Ricerca sul Cancro (AIRC, Milano, Italy) and Consiglio probe for oligonucleotide hybridization. 11 The FR3 method Nazionale delle Ricerche (Progetto Finalizzato ACRO specificity is then based on one tumor-specific marker and this 9500416.PF39) and BIOMED grant ERBCMRXCT940473. MA may increase the risk of false positive results. In order to avoid is a recipient of a fellowship from AIRC. We are indebted to these problems we adopted a different strategy based on the Dr SS Sahota and Dr FK Stevenson for sending us the amplification of a longer fragment of the tumor VDJ by using sequence of framework and leader region families. sense primers derived from the leader or FR1 region. This approach allows the reading of both CDRII and CDRIII. The reading of two different tumor-specific sequences for each References patient is essential to develop a sensitive and specific method for MRD detection characterized by two step specificity: a probe. 18, 24, 28 In order to simplify such an approach, we This strategy is sometimes difficult to achieve because well Chai J-R, Wang ZY, Waxmann S, Chen Z, Chen S-J. Acute promyepreserved samples for RNA extraction are not always availlocytic leukemia: clinical relevance of two major PML/RAR-␣ isoforms and detection of minimal residual disease by retroable. In both amplification CDRs, derived sense primers and
